Search
LakeShore Biopharma Co Ltd
LSBAdd to Watchlist
0.627USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
13.02MMarket Cap
--P/E TTM
More Details of LakeShore Biopharma Co Ltd Company
LakeShore Biopharma Co Ltd, formerly YS Biopharma Co Ltd, is a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The Company's vaccine product YSJATM rabies vaccine has been commercialized. The Company also has four product candidates under various clinical development stages, including PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, PIKA YS-ON-001 and PIKA YS-HBV-001, and four preclinical stage product candidates, targeting HBV, influenza and cancer with enormous medical demand. In addition, the Company is working on a series of therapeutic targets, rabies and products at the discovery stage.
LakeShore Biopharma Co Ltd Info
Ticker SymbolLSB
Company nameLakeShore Biopharma Co Ltd
IPO dateJul 30, 2021
CEOMr. Dave Chenn
Number of employees573
Security typeOrdinary Share
Fiscal year-endJul 30
AddressBuilding No. 2, 38 Yongda Road
CityBEIJING
Stock exchangeNASDAQ Capital Market Consolidated
CountryChina
Postal code102629
Phone
Websitehttps://www.ysbiopharm.com/
Ticker SymbolLSB
IPO dateJul 30, 2021
CEOMr. Dave Chenn
Company Executives of LakeShore Biopharma Co Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Yi Zhang
Mr. Yi Zhang
Chairman of the Board
Chairman of the Board
4.91M
--
Mr. Dave Chenn
Mr. Dave Chenn
Interim Co-Chief Executive Officer, Director
Interim Co-Chief Executive Officer, Director
462.76K
--
Dr. Hui (David) Shao
Dr. Hui (David) Shao
President, Co-Chief Executive Officer, Director, Chief Business Officer
President, Co-Chief Executive Officer, Director, Chief Business Officer
313.64K
--
Ms. Chunyuan Wu
Ms. Chunyuan Wu
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Zenaida Reynoso Mojares
Dr. Zenaida Reynoso Mojares
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Chunyang Shao
Mr. Chunyang Shao
Director
Director
--
--
Mr. Gang Li
Mr. Gang Li
Head of Marketing and sales
Head of Marketing and sales
--
--
Dr. Stanley Yi Chang
Dr. Stanley Yi Chang
Independent Director
Independent Director
--
--
Dr. Ajit Shetty
Dr. Ajit Shetty
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Thomas Xue
Mr. Thomas Xue
Director
Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Yi Zhang
Mr. Yi Zhang
Chairman of the Board
Chairman of the Board
4.91M
--
Mr. Dave Chenn
Mr. Dave Chenn
Interim Co-Chief Executive Officer, Director
Interim Co-Chief Executive Officer, Director
462.76K
--
Dr. Hui (David) Shao
Dr. Hui (David) Shao
President, Co-Chief Executive Officer, Director, Chief Business Officer
President, Co-Chief Executive Officer, Director, Chief Business Officer
313.64K
--
Ms. Chunyuan Wu
Ms. Chunyuan Wu
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Zenaida Reynoso Mojares
Dr. Zenaida Reynoso Mojares
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Chunyang Shao
Mr. Chunyang Shao
Director
Director
--
--
FAQs
Who are the top five shareholders of LakeShore Biopharma Co Ltd?
The top five shareholders of LakeShore Biopharma Co Ltd are: Mr. Yi Zhang
How many institutions hold shares of LakeShore Biopharma Co Ltd (LSB)?
As of 2026Q1, 18 institutions hold shares of LakeShore Biopharma Co Ltd, with a combined market value of approximately 606.46K, accounting for 1.47% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -1434782.00.